Combination Therapy with Telmisartan and Oxacalcitriol Suppresses the Progression of Murine Adriamycin Nephropathy | Zendy

Kyung Hwan Jeong | Zendy; Katsuhiko Asanuma | Zendy; Aida Lydia | Zendy; Miyuki Takagi | Zendy; Rin Asao | Zendy; Fumiko Kodama | Zendy; Etsuko Asanuma | Zendy; Yasuhiko Tomino | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Combination Therapy with Telmisartan and Oxacalcitriol Suppresses the Progression of Murine Adriamycin Nephropathy

Author(s) -

Kyung Hwan Jeong,

Katsuhiko Asanuma,

Aida Lydia,

Miyuki Takagi,

Rin Asao,

Fumiko Kodama,

Etsuko Asanuma,

Yasuhiko Tomino

Publication year - 2015

Publication title -

the nephron journals/nephron journals

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.951

H-Index - 72

eISSN - 2235-3186

pISSN - 1660-8151

DOI - 10.1159/000369346

Subject(s) - medicine , telmisartan , nephrin , podocin , glomerulosclerosis , podocyte , albuminuria , endocrinology , diabetic nephropathy , nephropathy , valsartan , irbesartan , angiotensin ii , pharmacology , kidney , blood pressure , proteinuria , diabetes mellitus

Blockade of the renin-angiotensin system plays a key role in suppressing the progression of renal diseases. It has not been well established whether this therapy provides additional effects when combined with vitamin D or its analog in a model of adriamycin (ADR)-induced nephropathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research